Ashley Vassallo is a 37-year-old mother of 2 young boys living in Northern California. Formerly a hospice social worker, she now works as a patient advocate focused on raising awareness of lung cancer in young women without a smoking [...]
Innovative decentralized trial aims to increase patient participation and accelerate research for one of the deadliest, under-researched lung cancers SAN CARLOS, CA – June 12, 2025 — GO2 for Lung Cancer (GO2) and the Addario Lung Cancer Medical Institute [...]
A statement from GO2 for Lung Cancer’s President and CEO Laurie Ambrose on the proposed federal budget cuts The President recently submitted a Fiscal Year 2026 budget request that proposes yet again deep cuts to and elimination of key [...]
Question: I’d like to start looking at whether a clinical trial might be good for me, but the process seems overwhelming. Where should I start? What are the best resources for me to understand my options? Answer: Whenever you [...]
Anne Charity Hudley, PhD, is associate dean of educational affairs and professor of education at Stanford University. She grew up just outside of Richmond, VA, and her ride home from school each evening through Richmond's Shockoe Bottom area smelled [...]
When people think about treatment options after receiving a lung cancer diagnosis, they often don’t think about clinical trials. In fact, many people are fearful of exploring clinical trials and may shy away from discussing them with their care [...]
Clinical Trial Aims to Unlock the Origins of Lung Cancer WASHINGTON and BOSTON, April 17, 2024 – In a promising step forward, GO2 for Lung Cancer (GO2), Dana-Farber Cancer Institute (Dana-Farber), and the Addario Lung Cancer Medical Institute (ALCMI), [...]
Clinical trials are a critical part of developing future treatments for lung cancer and other diseases, but low enrollment indicates that they are also often misunderstood by people who might benefit from them. In June’s Lung Cancer Living Room, [...]
By Daniel A. Saez, M.Sc., Treatment and Trials Navigator, GO2 for Lung Cancer Patients often hear the words clinical trial and don’t know what to expect or sometimes even what a clinical trial is. GO2 for Lung Cancer has [...]
Increasing diversity within lung cancer clinical trials is of critical importance for patients, caregivers, and researchers. To make sure that you are informed and prepared to share the message, we’ve pulled together some helpful blog posts and downloadable materials [...]